The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
以乳糖和晶纤维素作为主要辅料制备
特
粉化物,并以此制备片剂,辅以预胶化淀粉调节片剂
溶出
。
The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
以乳糖和晶纤维素作为主要辅料制备
特
粉化物,并以此制备片剂,辅以预胶化淀粉调节片剂
溶出
。
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
观察
粒化
特对IV型高脂血症患者血清低密
脂蛋白(LDL)亚组份再分布
作用。
Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
类似,
特和联合治疗显著升高有浮力
LDL在总LDL中
比例。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件观点;若发现问题,欢迎向我们指正。
The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
以乳糖和晶纤维素作
辅料制备非诺贝特的
粉化物,并以此制备片剂,辅以预胶化淀粉调节片剂的溶出度。
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
目的观察粒化非诺贝特对IV型高脂血症患者血清低密度脂蛋白(LDL)亚组份再分布的作用。
Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
类似的,非诺贝特和疗显著升高有浮力的LDL在总LDL中的比例。
声明:以上例句、词性分类均由互网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
以乳糖和晶纤维素
为主要辅料制备非诺贝特
化物,并以此制备片剂,辅以预胶化淀
调节片剂
溶出度。
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
目观察
粒化非诺贝特对IV型高脂血症患者血清低密度脂蛋白(LDL)亚组份再分布
。
Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
类似,非诺贝特和联合治疗显著升高有浮力
LDL在总LDL中
比例。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件观点;若发现问题,欢迎向我们指正。
The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
以乳糖和晶纤维素作为主要辅料制备非诺贝特
粉化物,并以此制备
,辅以预胶化淀粉调节
溶出度。
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
目观察
粒化非诺贝特对IV
血症患者血清低密度
蛋白(LDL)亚组份再分布
作用。
Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
类似,非诺贝特和联合治疗显著升
有浮力
LDL在总LDL中
比例。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件观点;若发现问题,欢迎向我们指正。
The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
以乳糖和素作为主要辅料制备非诺贝特的
粉化物,并以此制备片剂,辅以预胶化淀粉调节片剂的溶出度。
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
目的观察粒化非诺贝特对IV型
脂血症患者血清低密度脂蛋白(LDL)亚组份再分布的作用。
Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
类似的,非诺贝特和联合治疗显有浮力的LDL在总LDL中的比例。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
以乳糖和晶纤维素作为主要辅料
非诺贝特的
粉化物,并以
片剂,辅以预胶化淀粉调节片剂的溶出度。
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
目的观察粒化非诺贝特对IV型高脂血症患者血清低密度脂蛋
(LDL)
份再分布的作用。
Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
类似的,非诺贝特和联合治疗显著升高有浮力的LDL在总LDL中的比例。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
和
晶纤维素作为主要辅料制备非诺贝特
粉化物,并
此制备片剂,辅
预胶化淀粉调节片剂
溶出度。
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
目观察
粒化非诺贝特对IV型高脂血症患者血清低密度脂蛋白(LDL)亚组份再分布
作用。
Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
类似,非诺贝特和联合治疗显著升高有浮
LDL
总LDL中
比例。
声明:上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
以乳糖和晶纤维素作为主要辅料制备非诺贝特
,并以此制备片剂,辅以预胶
淀
调节片剂
溶出度。
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
目观察
粒
非诺贝特对IV型高脂血症患者血清低密度脂蛋白(LDL)亚组份再
作用。
Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
类似,非诺贝特和联合治疗显著升高有浮力
LDL在总LDL中
比例。
声明:以上例句、词性类均由互联网资源自动生成,部
未经过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
乳糖和
晶纤维素作为主要辅料制备非诺贝特的
粉化
,
此制备片剂,辅
预胶化淀粉调节片剂的溶出度。
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
目的观察粒化非诺贝特对IV型高脂血症患者血清低密度脂蛋白(LDL)亚组
布的作用。
Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
类似的,非诺贝特和联合治疗显著升高有浮力的LDL在总LDL中的比例。
声明:上例句、词性
类均由互联网资源自动生成,部
未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。